Developmental-Behavioral Pediatric Research
Dr. Angkustsiri's research includes the behavioral and psychophysiological investigation of anxiety and social impairments in children with chromosome 22q11.2 deletion syndrome, including the influence of environmental fit and parenting. She is also involved in clinical trials in individuals with autism and fragile X syndrome. Other interests include the role of the immune system and microbiome in autism spectrum disorders.
Dr. Hagerman's research includes molecular and clinical studies in individuals with the full mutation of fragile X and those with the premutation. Studies also focus on the correlation of molecular parameters including the FMRP level and cognitive and physical features associated with fragile X syndrome. She also investigates the molecular, clinical, and pathological basis of fragile X- associated tremor/ataxia syndrome (FXTAS). In addition, she studies the association between fragile X and autism and she has carried out many targeted treatment trials for those with fragile X syndrome, ASD as well as FXTAS.
Dr. Hansen's research involves investigation of the genetic and environmental influences on the etiology and treatment of neurodevelopmental disorders, particularly autism spectrum disorders. She also studies the developmental and behavioral outcomes of infants and young children at risk because of biomedical and psychosocial factors and is involved in a state-wide demonstration project to provide comprehensive developmental screening and expanded intervention services to at-risk families. Dr. Hansen is the site PI for DBPNet, a national research network of 14 sites prioritizing clinical research in developmental behavioral pediatrics.